Mar 12 |
Psyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future Milestones
|
Mar 11 |
Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
|
Mar 11 |
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
|
Mar 11 |
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division
|
Mar 6 |
Psyence Biomedical’s Subsidiary, Psyence Australia, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
|
Jan 23 |
Newcourt Acquisition Corp Announces Continuation of Business Combination Close Process
|
Jan 23 |
Newcourt, Psyence SPAC merger approved but may not close
|
Jan 18 |
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Jan 16 |
Psyence's unit signs deal for up to $10M in funding via issuance of convertible notes
|
Jan 16 |
Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination
|